GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **51 - 75** of **4050** in total

« First

‹ Prev

1

2

3

4

5

6

7

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G00051MO	63
IgG	Patient 3	11	mild	G00051MO	47
IgM	Patient 3	-180	mild	G00051MO	129
IgA	Patient 3	4	mild	G00051MO	370
IgG	Patient 3	4	mild	G00051MO	41
IgM	Patient 3	11	mild	G00051MO	120
IgM	Patient 3	4	mild	G00051MO	108
IgA	Patient 4	12	mild	G00051MO	399
IgG	Patient 4	12	mild	G00051MO	94
IgM	Patient 4	12	mild	G00051MO	164
IgA	Patient 1	10	moderate	G00052MO	390
IgA	Patient 1	22	moderate	G00052MO	282
IgA	Patient 1	6	moderate	G00052MO	289
IgG	Patient 1	10	moderate	G00052MO	24
IgG	Patient 1	22	moderate	G00052MO	25
IgG	Patient 1	6	moderate	G00052MO	25
IgM	Patient 1	10	moderate	G00052MO	37
IgM	Patient 1	22	moderate	G00052MO	51
IgA	Patient 2	15	mild	G00052MO	281
IgA	Patient 2	24	mild	G00052MO	321
IgG	Patient 2	15	mild	G00052MO	33
IgG	Patient 2	24	mild	G00052MO	29
IgM	Patient 2	15	mild	G00052MO	62
IgM	Patient 2	24	mild	G00052MO	54
IgM	Patient 1	6	moderate	G00052MO	36